Logo image of SBNOR.OL

SPAREBANKEN NORGE (SBNOR.OL) Stock Fundamental Analysis

Europe - Euronext Oslo - OSL:SBNOR - NO0006000900 - Common Stock

194 NOK
-0.32 (-0.16%)
Last: 12/23/2025, 7:00:00 PM
Fundamental Rating

3

Overall SBNOR gets a fundamental rating of 3 out of 10. We evaluated SBNOR against 114 industry peers in the Banks industry. SBNOR has a bad profitability rating. Also its financial health evaluation is rather negative. SBNOR is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

SBNOR had positive earnings in the past year.
In the past year SBNOR had a positive cash flow from operations.
Each year in the past 5 years SBNOR has been profitable.
Each year in the past 5 years SBNOR had a positive operating cash flow.
SBNOR.OL Yearly Net Income VS EBIT VS OCF VS FCFSBNOR.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

1.2 Ratios

SBNOR has a worse Return On Assets (0.38%) than 80.70% of its industry peers.
Looking at the Return On Equity, with a value of 4.37%, SBNOR is doing worse than 75.44% of the companies in the same industry.
Industry RankSector Rank
ROA 0.38%
ROE 4.37%
ROIC N/A
ROA(3y)0.49%
ROA(5y)0.45%
ROE(3y)6.19%
ROE(5y)5.61%
ROIC(3y)N/A
ROIC(5y)N/A
SBNOR.OL Yearly ROA, ROE, ROICSBNOR.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6

1.3 Margins

SBNOR has a Profit Margin (22.44%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of SBNOR has grown nicely.
The Operating Margin and Gross Margin are not available for SBNOR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 22.44%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y12.59%
PM growth 5Y16.7%
GM growth 3YN/A
GM growth 5YN/A
SBNOR.OL Yearly Profit, Operating, Gross MarginsSBNOR.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1

2. Health

2.1 Basic Checks

SBNOR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SBNOR remains at a similar level compared to 1 year ago.
SBNOR has more shares outstanding than it did 5 years ago.
SBNOR has a worse debt/assets ratio than last year.
SBNOR.OL Yearly Shares OutstandingSBNOR.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SBNOR.OL Yearly Total Debt VS Total AssetsSBNOR.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100B 200B 300B

2.2 Solvency

The Debt to FCF ratio of SBNOR is 52.75, which is on the high side as it means it would take SBNOR, 52.75 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of SBNOR (52.75) is better than 61.40% of its industry peers.
SBNOR has a Debt/Equity ratio of 5.82. This is a high value indicating a heavy dependency on external financing.
SBNOR has a Debt to Equity ratio of 5.82. This is amonst the worse of the industry: SBNOR underperforms 89.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.82
Debt/FCF 52.75
Altman-Z N/A
ROIC/WACCN/A
WACC5.99%
SBNOR.OL Yearly LT Debt VS Equity VS FCFSBNOR.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
SBNOR.OL Yearly Current Assets VS Current LiabilitesSBNOR.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

6

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.72% over the past year.
SBNOR shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.42% yearly.
Looking at the last year, SBNOR shows a very strong growth in Revenue. The Revenue has grown by 25.49%.
The Revenue has been growing by 10.96% on average over the past years. This is quite good.
EPS 1Y (TTM)3.72%
EPS 3Y22.09%
EPS 5Y17.42%
EPS Q2Q%-9.89%
Revenue 1Y (TTM)25.49%
Revenue growth 3Y9.69%
Revenue growth 5Y10.96%
Sales Q2Q%61.36%

3.2 Future

SBNOR is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -0.32% yearly.
SBNOR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.75% yearly.
EPS Next Y-2.43%
EPS Next 2Y-2.02%
EPS Next 3Y-0.32%
EPS Next 5YN/A
Revenue Next Year49.98%
Revenue Next 2Y30.34%
Revenue Next 3Y20.75%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SBNOR.OL Yearly Revenue VS EstimatesSBNOR.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
SBNOR.OL Yearly EPS VS EstimatesSBNOR.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5 10 15

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 11.42 indicates a reasonable valuation of SBNOR.
SBNOR's Price/Earnings ratio is in line with the industry average.
SBNOR's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.59.
A Price/Forward Earnings ratio of 12.14 indicates a correct valuation of SBNOR.
Based on the Price/Forward Earnings ratio, SBNOR is valued a bit more expensive than the industry average as 69.30% of the companies are valued more cheaply.
SBNOR's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.03.
Industry RankSector Rank
PE 11.42
Fwd PE 12.14
SBNOR.OL Price Earnings VS Forward Price EarningsSBNOR.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

SBNOR's Price/Free Cash Flow ratio is rather cheap when compared to the industry. SBNOR is cheaper than 80.70% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.14
EV/EBITDA N/A
SBNOR.OL Per share dataSBNOR.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.66
EPS Next 2Y-2.02%
EPS Next 3Y-0.32%

6

5. Dividend

5.1 Amount

SBNOR has a Yearly Dividend Yield of 4.51%, which is a nice return.
SBNOR's Dividend Yield is a higher than the industry average which is at 4.12.
Compared to an average S&P500 Dividend Yield of 1.88, SBNOR pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.51%

5.2 History

The dividend of SBNOR is nicely growing with an annual growth rate of 42.04%!
Dividend Growth(5Y)42.04%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

SBNOR pays out 107.44% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of SBNOR has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP107.44%
EPS Next 2Y-2.02%
EPS Next 3Y-0.32%
SBNOR.OL Yearly Income VS Free CF VS DividendSBNOR.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B
SBNOR.OL Dividend Payout.SBNOR.OL Dividend Payout, showing the Payout Ratio.SBNOR.OL Dividend Payout.PayoutRetained Earnings

SPAREBANKEN NORGE

OSL:SBNOR (12/23/2025, 7:00:00 PM)

194

-0.32 (-0.16%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)11-07 2025-11-07/bmo
Earnings (Next)01-30 2026-01-30
Inst Owners23.91%
Inst Owner ChangeN/A
Ins Owners0.53%
Ins Owner ChangeN/A
Market Cap33.62B
Revenue(TTM)8.97B
Net Income(TTM)2.17B
Analysts75.71
Price Target187.43 (-3.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.51%
Yearly Dividend24.37
Dividend Growth(5Y)42.04%
DP107.44%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.12%
Min EPS beat(2)5.31%
Max EPS beat(2)18.92%
EPS beat(4)3
Avg EPS beat(4)8.84%
Min EPS beat(4)-3.55%
Max EPS beat(4)18.92%
EPS beat(8)7
Avg EPS beat(8)6.95%
EPS beat(12)9
Avg EPS beat(12)14.09%
EPS beat(16)12
Avg EPS beat(16)13.94%
Revenue beat(2)1
Avg Revenue beat(2)-5.12%
Min Revenue beat(2)-13.13%
Max Revenue beat(2)2.89%
Revenue beat(4)2
Avg Revenue beat(4)-0.72%
Min Revenue beat(4)-13.13%
Max Revenue beat(4)8.42%
Revenue beat(8)6
Avg Revenue beat(8)4.18%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)8.57%
PT rev (3m)10.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.16%
EPS NY rev (1m)4.05%
EPS NY rev (3m)7.01%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.37%
Revenue NY rev (1m)0.86%
Revenue NY rev (3m)1.4%
Valuation
Industry RankSector Rank
PE 11.42
Fwd PE 12.14
P/S 3.48
P/FCF 6.14
P/OCF 6.05
P/B 0.68
P/tB 0.77
EV/EBITDA N/A
EPS(TTM)16.99
EY8.76%
EPS(NY)15.98
Fwd EY8.24%
FCF(TTM)31.59
FCFY16.29%
OCF(TTM)32.06
OCFY16.53%
SpS55.7
BVpS286.14
TBVpS250.64
PEG (NY)N/A
PEG (5Y)0.66
Graham Number330.73
Profitability
Industry RankSector Rank
ROA 0.38%
ROE 4.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 22.44%
GM N/A
FCFM 56.72%
ROA(3y)0.49%
ROA(5y)0.45%
ROE(3y)6.19%
ROE(5y)5.61%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y12.59%
PM growth 5Y16.7%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 5.82
Debt/FCF 52.75
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.84%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 252.8%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC5.99%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)1.41%
Cap/Sales(5y)1.57%
Profit Quality(3y)228.55%
Profit Quality(5y)217.4%
High Growth Momentum
Growth
EPS 1Y (TTM)3.72%
EPS 3Y22.09%
EPS 5Y17.42%
EPS Q2Q%-9.89%
EPS Next Y-2.43%
EPS Next 2Y-2.02%
EPS Next 3Y-0.32%
EPS Next 5YN/A
Revenue 1Y (TTM)25.49%
Revenue growth 3Y9.69%
Revenue growth 5Y10.96%
Sales Q2Q%61.36%
Revenue Next Year49.98%
Revenue Next 2Y30.34%
Revenue Next 3Y20.75%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y60.23%
FCF growth 3Y28.27%
FCF growth 5Y61.38%
OCF growth 1Y56.82%
OCF growth 3Y27.09%
OCF growth 5Y18.41%

SPAREBANKEN NORGE / SBNOR.OL FAQ

Can you provide the ChartMill fundamental rating for SPAREBANKEN NORGE?

ChartMill assigns a fundamental rating of 3 / 10 to SBNOR.OL.


Can you provide the valuation status for SPAREBANKEN NORGE?

ChartMill assigns a valuation rating of 4 / 10 to SPAREBANKEN NORGE (SBNOR.OL). This can be considered as Fairly Valued.


What is the profitability of SBNOR stock?

SPAREBANKEN NORGE (SBNOR.OL) has a profitability rating of 3 / 10.


What is the valuation of SPAREBANKEN NORGE based on its PE and PB ratios?

The Price/Earnings (PE) ratio for SPAREBANKEN NORGE (SBNOR.OL) is 11.42 and the Price/Book (PB) ratio is 0.68.


What is the financial health of SPAREBANKEN NORGE (SBNOR.OL) stock?

The financial health rating of SPAREBANKEN NORGE (SBNOR.OL) is 1 / 10.